Marshall Wace North America’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $951K | Sell |
6,541
-47,448
| -88% | -$6.9M | ﹤0.01% | 909 |
|
|
2021
Q2 | $7.12M | Buy |
53,989
+40,573
| +302% | +$5.35M | 0.03% | 448 |
|
|
2021
Q1 | $1.72M | Sell |
13,416
-80,922
| -86% | -$10.4M | 0.01% | 858 |
|
|
2020
Q4 | $11.2M | Buy |
94,338
+88,858
| +1,621% | +$10.6M | 0.05% | 352 |
|
|
2020
Q3 | $627K | Sell |
5,480
-478,514
| -99% | -$54.7M | ﹤0.01% | 918 |
|
|
2020
Q2 | $55.2M | Sell |
483,994
-724,663
| -60% | -$82.6M | 0.36% | 75 |
|
|
2020
Q1 | $97.1M | Sell |
1,208,657
-1,063,782
| -47% | -$85.4M | 0.74% | 32 |
|
|
2019
Q4 | $243M | Buy |
2,272,439
+216,327
| +11% | +$23.1M | 1.17% | 17 |
|
|
2019
Q3 | $220M | Buy |
2,056,112
+275,530
| +15% | +$29.5M | 1.25% | 11 |
|
|
2019
Q2 | $181M | Buy |
1,780,582
+448,332
| +34% | +$45.6M | 1.13% | 18 |
|
|
2019
Q1 | $120M | Sell |
1,332,250
-235,820
| -15% | -$21.2M | 0.85% | 25 |
|
|
2018
Q4 | $131M | Sell |
1,568,070
-524,796
| -25% | -$43.7M | 1.26% | 15 |
|
|
2018
Q3 | $226M | Sell |
2,092,866
-565,264
| -21% | -$61M | 1.55% | 13 |
|
|
2018
Q2 | $292M | Buy |
2,658,130
+214,446
| +9% | +$23.6M | 1.65% | 3 |
|
|
2018
Q1 | $245M | Buy |
2,443,684
+586,085
| +32% | +$58.8M | 1.23% | 7 |
|
|
2017
Q4 | $183M | Buy |
1,857,599
+1,700,001
| +1,079% | +$167M | 1.01% | 9 |
|
|
2017
Q3 | $14.8M | Sell |
157,598
-599,886
| -79% | -$56.4M | 0.09% | 275 |
|
|
2017
Q2 | $84.1M | Buy |
757,484
+330
| +0% | +$36.6K | 0.61% | 26 |
|
|
2017
Q1 | $74.2M | Buy |
+757,154
| New | +$74.2M | 0.59% | 31 |
|
|
2013
Q3 | – | Sell |
-4,698
| Closed | -$285K | – | 627 |
|
|
2013
Q2 | $285K | Buy |
+4,698
| New | +$285K | 0.02% | 368 |
|